Specifically, we investigated the extent to which APOE modulated the association between mIns concentration and both hallmarks of Alzheimer’s disease pathology, Aβ and tau, quantified by 18F-flutemetamol PET and 18F-RO948 PET, respectively. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.